Literature DB >> 22216499

Comparison of oral theophylline and salbutamol by inhalation in asthmatic patients.

B J Hartnett1, G E Marlin.   

Abstract

The bronchodilator effects of 375 mg theophylline orally and 200 microg salbutamol by pressurized aerosol were compared in a randomized, cross-over, double-blind trial in fourteen asthmatic patients. The mean peak percentage FEV1 increase from control was 43.7% at 60 min after salbutamol and 30.3% at 180 min after theophylline. Salbutamol produced significantly greater bronchodilatation than theophylline for the initial 30 min (P < 0.01). Theophylline demonstrated a longer duration of action than salbutamol, with a significantly greater FEV1 response at 360 min (P < 0.02). There was no significant difference between the total effect of each drug for the 360 min period, as calculated by the areas under the respective FEV1 response curves.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 22216499      PMCID: PMC1428911          DOI: 10.1111/j.1365-2125.1976.tb04880.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  4 in total

1.  Study of theophylline plasma levels after oral administration of new theophylline compounds.

Authors:  M TURNER-WARWICK
Journal:  Br Med J       Date:  1957-07-13

2.  The clinical pharmacology of oral and inhaled salbutamol.

Authors:  S R Walker; M E Evans; A J Richards; J W Paterson
Journal:  Clin Pharmacol Ther       Date:  1972 Nov-Dec       Impact factor: 6.875

3.  Pharmacokinetics of theophylline. Application to adjustment of the clinical dose of aminophylline.

Authors:  J W Jenne; M S Wyze; F S Rood; F M MacDonald
Journal:  Clin Pharmacol Ther       Date:  1972 May-Jun       Impact factor: 6.875

4.  CLINICAL EVALUATION OF ELIXOPHYLLIN WITH CORRELATION OF PULMONARY FUNCTION STUDIES AND THEOPHYLLINE SERUM LEVELS IN ACUTE AND CHRONIC ASTHMATIC PATIENTS.

Authors:  R H JACKSON; J I MCHENRY; F B MORELAND; W J RAYMER; R L ETTER
Journal:  Dis Chest       Date:  1964-01
  4 in total
  4 in total

1.  Concurrent oral and inhalation drug delivery using a dual formulation system: the use of oral theophylline carrier with combined inhalable budesonide and terbutaline.

Authors:  Rania O Salama; Paul M Young; Daniela Traini
Journal:  Drug Deliv Transl Res       Date:  2014-06       Impact factor: 4.617

Review 2.  Clinical relevance of pharmacokinetics.

Authors:  G Tognoni; C Bellantuono; M Bonati; M D'Incalci; M Gerna; R Latini; M Mandelli; M G Porro; E Riva
Journal:  Clin Pharmacokinet       Date:  1980 Mar-Apr       Impact factor: 6.447

3.  Pharmacokinetics of a microcrystalline theophylline preparation in patients with chronic obstructive airways disease.

Authors:  R K Elwood; J G Kelly; D G McDevitt
Journal:  Eur J Clin Pharmacol       Date:  1978-03-17       Impact factor: 2.953

4.  Plasma theophylline level and effect on lung function after oral and rectal administration of aminophylline.

Authors:  H Lamont; E Moerman; M Bogaert; M Van Der Straeten; R Pauwels
Journal:  Eur J Clin Pharmacol       Date:  1979-07       Impact factor: 2.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.